Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin

被引：0
|
作者：
Cheryl A Sherman-Baust
Kevin G Becker
William H Wood III
Yongqing Zhang
Patrice J Morin
机构：
[1] National Institute on Aging,Laboratory of Molecular Biology and Immunology
[2] National Institute on Aging,Research Resource Branch
[3] Johns Hopkins Medical Institutions,Department of Pathology
来源：
Journal of Ovarian Research | / 4卷
关键词：
Ovarian Cancer; Paclitaxel; Doxorubicin; Drug Resistance; Ovarian Cancer Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells
    Wang, Juan
    Wu, Gen Sheng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (24) : 17163 - 17173
  • [32] Decreased Expression of Enolase-I Promotes Cisplatin Resistance of Ovarian Cancer Cells
    Rabelo-Fernandez, Robert Joe
    Vivas-Mejia, Pablo
    Santana-Rivera, Yasmarie
    FASEB JOURNAL, 2019, 33
  • [33] Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells
    Yang, Ling
    Li, Hongyan
    Jiang, Yizhou
    Zuo, Ji
    Liu, Wen
    CANCER LETTERS, 2013, 336 (01) : 213 - 221
  • [34] Label free quantitative proteomics analysis on the cisplatin resistance in ovarian cancer cells
    Wang, F.
    Zhu, Y.
    Fang, S.
    Li, S.
    Liu, S.
    CELLULAR AND MOLECULAR BIOLOGY, 2017, 63 (05) : 25 - 28
  • [35] Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
    Gamarra-Luques, Carlos D.
    Hapon, Maria B.
    Goyeneche, Alicia A.
    Telleria, Carlos M.
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [36] Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
    Carlos D Gamarra-Luques
    Maria B Hapon
    Alicia A Goyeneche
    Carlos M Telleria
    Journal of Ovarian Research, 7
  • [37] Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
    Feifei Xu
    Fengliang Wang
    Ting Yang
    Yuan Sheng
    Ting Zhong
    Yun Chen
    Cancer Cell International, 14
  • [38] Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
    Xu, Feifei
    Wang, Fengliang
    Yang, Ting
    Sheng, Yuan
    Zhong, Ting
    Chen, Yun
    CANCER CELL INTERNATIONAL, 2014, 14
  • [39] Comprehensive proteomic analysis of cisplatin resistance in ovarian cancer
    Teng, Pang-ning
    Hood, Brian L.
    Litzi, Tracy
    Chappell, Nicole P.
    Hamilton, Chad A.
    Maxwell, G. Larry
    Conrads, Thomas P.
    CANCER RESEARCH, 2012, 72
  • [40] Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
    Chappell, Nicole P.
    Teng, Pang-ning
    Hood, Brian L.
    Wane, Guisong
    Darcy, Kathleen M.
    Hamilton, Chad A.
    Maxwell, G. Larry
    Conrads, Thomas P.
    JOURNAL OF PROTEOME RESEARCH, 2012, 11 (09) : 4605 - 4614
12345